Cargando…

International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma

Detalles Bibliográficos
Autores principales: Der Sarkissian, Samuel Antranig, Wargon, Orli, Sebaratnam, Deshan Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361929/
https://www.ncbi.nlm.nih.gov/pubmed/34409330
http://dx.doi.org/10.1016/j.jdin.2020.06.005
_version_ 1783738047583485952
author Der Sarkissian, Samuel Antranig
Wargon, Orli
Sebaratnam, Deshan Frank
author_facet Der Sarkissian, Samuel Antranig
Wargon, Orli
Sebaratnam, Deshan Frank
author_sort Der Sarkissian, Samuel Antranig
collection PubMed
description
format Online
Article
Text
id pubmed-8361929
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83619292021-08-17 International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma Der Sarkissian, Samuel Antranig Wargon, Orli Sebaratnam, Deshan Frank JAAD Int Commentary Elsevier 2020-07-31 /pmc/articles/PMC8361929/ /pubmed/34409330 http://dx.doi.org/10.1016/j.jdin.2020.06.005 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Der Sarkissian, Samuel Antranig
Wargon, Orli
Sebaratnam, Deshan Frank
International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title_full International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title_fullStr International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title_full_unstemmed International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title_short International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
title_sort international heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361929/
https://www.ncbi.nlm.nih.gov/pubmed/34409330
http://dx.doi.org/10.1016/j.jdin.2020.06.005
work_keys_str_mv AT dersarkissiansamuelantranig internationalheterogeneityinadmissioncriteriaandmonitoringfortheinitiationofpropranololininfantilehemangioma
AT wargonorli internationalheterogeneityinadmissioncriteriaandmonitoringfortheinitiationofpropranololininfantilehemangioma
AT sebaratnamdeshanfrank internationalheterogeneityinadmissioncriteriaandmonitoringfortheinitiationofpropranololininfantilehemangioma